title: Hypercoagulable state in the Watanabe heritable hyperlipidemic rabbit, an animal model for the progression of atherosclerosis. Effect of probucol on coagulation.
abstract: Blood coagulation in a strain of rabbits designated as Watanabe heritable hyperlipidemic (WHHL) rabbits was examined. The activities of vitamin K-dependent clotting factors, contact factors and clotting factor VIII (F VIII) and the fibrinogen level were significantly higher in WHHL rabbits than in normolipidemic rabbits (all age groups). Values for vitamin K-dependent clotting factor were already higher at 2 months of age. Contact factors and fibrinogen levels increased age after 5 to 8 months. F VIII increased between 5 and 8 months and then decreased. At 2 months of age, WHHL rabbits were divided into two groups. Group A was fed standard rabbit chow and group B standard rabbit chow containing 1% probucol. Probucol prevented the progression of atherosclerosis in group B in the absence of a significant reduction in plasma cholesterol level. F VIII and fibrinogen levels were statistically decreased in all rabbits at all ages in group B (P less than 0.05). These differences in clotting factors between the two groups were most obvious at 8 months (P less than 0.02). We conclude that vitamin K-dependent clotting factors may increase with hyperlipemia and that increases in F VIII and fibrinogen may be closely related to the progression of thromboatherosclerosis.
authors.affiliation: Second Department of Internal Medicine, Faculty of Medicine, Mie University, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Mori
authors.forename: H
authors.initials: H
authors.lastname: Wada
authors.forename: Y
authors.initials: Y
authors.lastname: Nagano
authors.forename: K
authors.initials: K
authors.lastname: Deguchi
authors.forename: T
authors.initials: T
authors.lastname: Kita
authors.forename: S
authors.initials: S
authors.lastname: Shirakawa
mesh_terms: D000375:Aging / Q000097:blood; D000818:Animals; D001161:Arteriosclerosis / Q000097:blood* / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000187:drug effects / Q000378:metabolism*; D004195:Disease Models, Animal; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy / Q000235:genetics; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D010636:Phenols / Q000627:therapeutic use*; D011341:Probucol / Q000627:therapeutic use*; D011817:Rabbits
chemical_list: D001779:Blood Coagulation Factors; D008055:Lipids; D008074:Lipoproteins; D010636:Phenols; D011341:Probucol